National provider directory faces both skepticism & support

The latest stories trending on MedCity News.

Editor's Pick

Top Story There Is 'Skepticism and Support' for National Provider Directory, CMS Official Says CMS put out a request for information in October about a CMS-led national provider directory that would allow patients to find and compare providers based on preferences like language and location. Alexandra Mugge, director and deputy chief health informatics officer of the Health Informatics and Interoperability Group at CMS, said there is stakeholder support for the national directory — if it's executed correctly. Save $600 with Spring Networking Madness We're ready for spring, are you? In our enthusiasm for spring, we're bringing you a special limited time discount of $600 to attend INVEST, the premier healthcare networking event of 2023. Offer Ends 3/26 - Register Now!

Featured News

Why Point-of-Care Diagnostic Filtering, Interoperability Are Essential in the Age of TEFCA, QHINs Without a new set of tools that clinicians can access at the point of care, the availability of information from QHINs will increase provider burdens because they will struggle to find the information needed to evaluate a patient, take action, complete documentation, and move to the next patient. Preserve Access to Home Oxygen Therapy Post-Pandemic CMS should honor its commitment to Medicare beneficiaries, especially those who began home respiratory therapy under the PHE, without requiring them to "restart" the documentation process. Requiring requalification would also be a nightmare for physicians who are already overwhelmed with patient demands. Labcorp Shells Out $146M to Buy Enzo Biochem's Clinical Lab Business Enzo BioChem's sale of its clinical lab business to Labcorp is the culmination of a monthslong strategic review. Meanwhile, diagnostics and lab testing giant Labcorp is in the middle of its own corporate shakeup as it readies its clinical trials business for a spinoff as a standalone, publicly traded company. Perspectum Completes $55M Series C to Improve Metabolic Disease Diagnosis Perspectum — a company that makes medical imaging devices designed to improve the diagnosis of metabolic diseases and cancer — recently announced the second close of its $55 million Series C funding round. Its flagship product is a diagnostic tool that assesses and monitors chronic liver disease.

Resources

Introducing MedCity Moves, a New Podcast on Healthcare's Corporate Ladder In the first episode, aside from providing an overview of healthcare's latest leadership and layoff news, Senior Reporter Katie Adams interviews Dr. Taha Kass-Hout, who recently became GE Healthcare's chief technology officer, about healthcare's corporate ladder. Listen Now

MedCity News • 611 Broadway • New York, NY unsubscribe